The Scientific Research and Development team at ANGLE spearheads the advancement of liquid biopsy technologies, focusing on the innovation and enhancement of Parsortix® for capturing circulating tumor cells. This multidisciplinary team, comprised of scientists and clinical laboratory experts, conducts research, develops assays, and ensures high-quality manufacturing processes to drive breakthroughs in cancer diagnostics and improve patient outcomes. Their collaborative efforts support both product development and clinical applications, contributing to ANGLE's position as a leader in the field.